Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ex-Teva Executive To Steer Dr Reddy’s As COO

Executive Summary

Erez Israeli, ex-Teva long-timer, is set to take over as Dr Reddy’s chief operating officer and global head of the generics and PSAI (pharmaceuticals services and active ingredients) businesses. Israeli’s appointment comes at a time when the Indian firm tackles multiple operational challenges, including compliance issues at its plants.


Related Content

Big Cost Cuts At Dr Reddy’s, US Big Ticket Launch Progress Is Key
Bad News Teva Really Doesn't Need: A Potential Delay For Fremanezumab
Dr Reddy’s Pins Hopes On Complex Drugs Pipeline Amid Weak Q3
Dr Reddy’s Charts Sharp Cost Overhaul Amid Weak Q1


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts